HECHT; Sidney M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for HECHT; Sidney M..The latest application filed is for "redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers".

Company Profile

0.16.11

HECHT; Sidney M. - Charlottesville VA
Hecht; Sidney M. - Charlottsville VA US
Hecht; Sidney M. - Newtonville MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Redox-active Therapeutics For Treatment Of Mitochondrial Diseases And Other Conditions And Modulation Of Energy Biomarkers App 20220055975 - Miller; Guy M. ; et al.	2022-02-24
Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers Grant 11,021,424 - Miller , et al. June 1, 2	2021-06-01
Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers Grant 9,932,286 - Miller , et al. April 3, 2	2018-04-03
Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers Grant 9,447,006 - Miller , et al. September 20, 2	2016-09-20
Side-chain Variants Of Redox-active Therapeutics For Treatment Of Mitochondrial Diseases And Other Conditions And Modulation Of Energy Biomarkers App 20160244392 - Miller; Guy M. ; et al.	2016-08-25
Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers Grant 9,278,085 - Miller , et al. March 8, 2	2016-03-08
Synthesis and identification of novel RSK-specific inhibitors Grant 9,040,673 - Hecht , et al. May 26, 2	2015-05-26
Rhamnose substituents of SL0101 and therapeutic uses thereof Grant 8,426,568 - Smith , et al. April 23, 2	2013-04-23
Synthesis And Identification Of Novel Rsk-specific Inhibitors App 20120245112 - Hecht; Sidney M. ; et al.	2012-09-27
Redox-active Therapeutics For Treatment Of Mitochondrial Diseases And Other Conditions And Modulation Of Energy Biomarkers App 20100222436 - Miller; Guy M. ; et al.	2010-09-02
Rhamnose Substituents Of Sl0101 And Therapeutic Uses Thereof App 20100016245 - Smith; Jeffrey A. ; et al.	2010-01-21
Synthesis of inhibitors of p90Rsk Grant 7,605,241 - Hecht , et al. October 20, 2	2009-10-20
Synthesis of Inhibitors of P90Rsk App 20080269144 - Hecht; Sidney M. ; et al.	2008-10-30
Tail variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers Grant 7,432,305 - Miller , et al. October 7, 2	2008-10-07
Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers App 20070225261 - Miller; Guy M. ; et al.	2007-09-27
Tail variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers App 20070072943 - Miller; Guy M. ; et al.	2007-03-29
Rsk inhibitors and therapeutic uses thereof App 20070049539 - Smith; Jeffrey A. ; et al.	2007-03-01
Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers App 20060281809 - Miller; Guy M. ; et al.	2006-12-14
Inhibitors of dna polymerase sigma App 20040029906 - Christman, Michael ; et al.	2004-02-12
Oligonucleotide N-alkylphosphoramidates Grant 5,519,126 - Hecht May 21, 1	1996-05-21
Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells Grant 5,004,758 - Boehm , et al. April 2, 1	1991-04-02
Synthesis for 7-alkylamino-3-methylpyrazolo [4,3-d]pyrimidines Grant 4,282,361 - Hecht , et al. August 4, 1	1981-08-04

Company Registrations

SEC

0001287694

HECHT SIDNEY M

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.